Telbivudine treatment started in early and middle pregnancy completely blocks HBV vertical transmission

BACKGROUND: To evaluate the efficacy and safety of treating HBV-positive mothers with telbivudine in early and middle pregnancy to prevent mother-to-infant HBV transmission. METHODS: The subject population comprised pregnant women with chronic hepatitis B (CHB; n = 188) from January 2013 to June 201...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Weihui, Zhao, Shangfei, Ma, Lei, Hao, Anhua, Zhao, Bo, Zhou, Lin, Li, Fengzhu, Song, Mingquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5390436/
https://www.ncbi.nlm.nih.gov/pubmed/28407735
http://dx.doi.org/10.1186/s12876-017-0608-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5390436/
https://www.ncbi.nlm.nih.gov/pubmed/28407735
http://dx.doi.org/10.1186/s12876-017-0608-7

Ejemplares similares